Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

The spliceosome is a therapeutic vulnerability in MYC-driven cancer.

Hsu TY, Simon LM, Neill NJ, Marcotte R, Sayad A, Bland CS, Echeverria GV, Sun T, Kurley SJ, Tyagi S, Karlin KL, Dominguez-VidaƱa R, Hartman JD, Renwick A, Scorsone K, Bernardi RJ, Skinner SO, Jain A, Orellana M, Lagisetti C, Golding I, Jung SY, Neilson JR, Zhang XH, Cooper TA, Webb TR, Neel BG, Shaw CA, Westbrook TF.

Nature. 2015 Sep 17;525(7569):384-8. doi: 10.1038/nature14985. Epub 2015 Sep 2.

2.

The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor.

Karlin KL, Mondal G, Hartman JK, Tyagi S, Kurley SJ, Bland CS, Hsu TY, Renwick A, Fang JE, Migliaccio I, Callaway C, Nair A, Dominguez-Vidana R, Nguyen DX, Osborne CK, Schiff R, Yu-Lee LY, Jung SY, Edwards DP, Hilsenbeck SG, Rosen JM, Zhang XH, Shaw CA, Couch FJ, Westbrook TF.

Cell Rep. 2014 Nov 20;9(4):1318-32. doi: 10.1016/j.celrep.2014.10.011. Epub 2014 Nov 6.

3.

Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis.

Singh RK, Xia Z, Bland CS, Kalsotra A, Scavuzzo MA, Curk T, Ule J, Li W, Cooper TA.

Mol Cell. 2014 Aug 21;55(4):592-603. doi: 10.1016/j.molcel.2014.06.035. Epub 2014 Jul 31.

4.

The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.

Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, Herschkowitz JI, Burrows AE, Ciccia A, Sun T, Schmitt EM, Bernardi RJ, Fu X, Bland CS, Cooper TA, Schiff R, Rosen JM, Westbrook TF, Elledge SJ.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70. doi: 10.1073/pnas.1019736108. Epub 2011 Feb 9.

5.

Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic.

Tai W, Roberts L, Seryshev A, Gubatan JM, Bland CS, Zabriskie R, Kulkarni S, Soong L, Mbawuike I, Gilbert B, Kheradmand F, Corry DB.

Mucosal Immunol. 2011 Mar;4(2):197-207. doi: 10.1038/mi.2010.50. Epub 2010 Aug 25.

PMID:
20736998
6.

Global regulation of alternative splicing during myogenic differentiation.

Bland CS, Wang ET, Vu A, David MP, Castle JC, Johnson JM, Burge CB, Cooper TA.

Nucleic Acids Res. 2010 Nov;38(21):7651-64. doi: 10.1093/nar/gkq614. Epub 2010 Jul 15.

7.

Micromanaging alternative splicing during muscle differentiation.

Bland CS, Cooper TA.

Dev Cell. 2007 Feb;12(2):171-2.

8.

Mycobacterial ecology of the Rio Grande.

Bland CS, Ireland JM, Lozano E, Alvarez ME, Primm TP.

Appl Environ Microbiol. 2005 Oct;71(10):5719-27.

9.

The UCLA School of Medicine.

Bland CS.

West J Med. 1985 May;142(5):712-6. No abstract available.

10.
11.

Investigation of a family with hypertrophic neuropathy resembling Roussy-Levy syndrome. Clinical, electrophysiologic, histologic, and biochemical studies.

Kriel RL, Cliffer KD, Berry J, Sung JH, Bland CS.

Neurology. 1974 Sep;24(9):801-9. No abstract available.

PMID:
4368842

Supplemental Content

Loading ...
Support Center